Predictors of long-term anamorelin hydrochloride use in patients with cancer cachexia: a single-center real-world retrospective study

Key Points

• This research aims to identify factors predictive of long-term use of anamorelin hydrochloride in cancer cachexia patients.
• Conducted a retrospective analysis at a single center
• Evaluated association between mGPS, ECOG PS, and anamorelin duration
• Included patients diagnosed with cancer cachexia
• Lower mGPS scores associated with longer anamorelin use
• Better ECOG PS correlated with prolonged treatment duration
• Patients with gastric cancer showed a tendency for shorter anamorelin use